Early Cardiovascular Risk Revealed By Vioxx Trial Data

Links shared publicly online about this topic.

  • 1,577
    total visits

Early Cardiovascular Risk Revealed By Vioxx Trial Data

medicalnewstoday.com —

Evidence of cardiovascular risks associated with taking vioxx, the popular, nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer, m

View full resource at medicalnewstoday.com

Tags: Drug, NSAIDs, Vioxx

  • Share

Most Recently Shared on November 25, 2009 at 1:27 pm By:

mnt_clinical MNT Clinical Trials

Early Cardiovascular Risk Revealed By Vioxx Trial Data: Evidence of cardiovascular risks associated with taking.. http://bit.ly/6G2y1B

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Cardiovascular MNT Cardiovascular

Advertisement